Asian Journal of Research in Chemistry

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

An Improved Synthesis of Finasteride from 4-Androsten-3,17-Dione


Affiliations
1 Department of Pharmaceutical Chemistry and Center for New Drugs Discovery and Development (C3D), Hanoi University of Pharmacy, 13-15 Le Thanh Tong, Hoan Kiem District, Hanoi, Viet Nam
     

   Subscribe/Renew Journal


An improved synthesis of 3-oxo-4-aza-5α-androst-1-ene-17β-(N-tert-butylcarboxamide), commonly known as finasteride (1), a drug widely used for the treatment of benign prostatic hyperplasia (BPH), has been implemented via seven steps in an overall yield of 20.01% starting from 4-androsten-3,17-dione (AD). Conditions of several steps have been improved to be less expensive and more commercially viable compared to reported synthesis in literature.

Keywords

Finasteride, Benign Prostatic Hyperplasia, Androst-4-En-3,17-Dione, Synthesis.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 195

PDF Views: 0




  • An Improved Synthesis of Finasteride from 4-Androsten-3,17-Dione

Abstract Views: 195  |  PDF Views: 0

Authors

Nguyen Hai Nam
Department of Pharmaceutical Chemistry and Center for New Drugs Discovery and Development (C3D), Hanoi University of Pharmacy, 13-15 Le Thanh Tong, Hoan Kiem District, Hanoi, Viet Nam
Ngo Anh Ngoc
Department of Pharmaceutical Chemistry and Center for New Drugs Discovery and Development (C3D), Hanoi University of Pharmacy, 13-15 Le Thanh Tong, Hoan Kiem District, Hanoi, Viet Nam

Abstract


An improved synthesis of 3-oxo-4-aza-5α-androst-1-ene-17β-(N-tert-butylcarboxamide), commonly known as finasteride (1), a drug widely used for the treatment of benign prostatic hyperplasia (BPH), has been implemented via seven steps in an overall yield of 20.01% starting from 4-androsten-3,17-dione (AD). Conditions of several steps have been improved to be less expensive and more commercially viable compared to reported synthesis in literature.

Keywords


Finasteride, Benign Prostatic Hyperplasia, Androst-4-En-3,17-Dione, Synthesis.